Stock SCPH SCPHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases scPharmaceuticals Inc.

Equities

SCPH

US8106481059

Real-time Estimate Cboe BZX
Other stock markets
 11:36:24 09/05/2024 pm IST 		5-day change 1st Jan Change
4.84 USD +3.20% Intraday chart for scPharmaceuticals Inc. +4.14% -22.60%
24/04 ScPharmaceuticals Inc. Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of Furoscix Auto-Injector (Furosemide 80Mg/Ml) Injection CI
13/03 Transcript : ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ScPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024
AQ
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector Injection
AQ
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
AQ
ScPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
AQ
ScPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
AQ
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences
AQ
ScPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
AQ
ScPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
AQ
ScPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
AQ
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences
AQ
ScPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
ScPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives
AQ
ScPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
AQ
ScPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
AQ
ScPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023
AQ
ScPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion
AQ
ScPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
ScPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
ScPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes
AQ
SCPHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SCPH Stock
  4. News scPharmaceuticals Inc.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW